Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
43,056,667
-
Total 13F shares
-
32,478,727
-
Share change
-
-140,201
-
Total reported value
-
$462,525,607
-
Put/Call ratio
-
0%
-
Price per share
-
$14.24
-
Number of holders
-
58
-
Value change
-
-$16,841,368
-
Number of buys
-
27
-
Number of sells
-
29
Institutional Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q1 2022
As of 31 Mar 2022,
Repare Therapeutics Inc. - Common Shares, no par value (RPTX) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,478,727 shares.
The largest 10 holders included
BVF INC/IL, ORBIMED ADVISORS LLC, FMR LLC, ARK Investment Management LLC, Redmile Group, LLC, Deep Track Capital, LP, CHI Advisors LLC, MPM ASSET MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, and BIOIMPACT CAPITAL LLC.
This page lists
58
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.